arrow
Back
R

Rana R. McKay

university of california san diego

57H-index
1.2KPaper Count
1.5WCitation Count
Published Papers 232
Publication Date
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-08-04
err0
errOAAI
errToni K. Choueiri; Jaime Merchán; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-07-01
err0
errOAAI
errToni K. Choueiri; Jamie Merchan; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer
err2026-05-15
err0
errOAAI
errAnna M. Dornisch; Mariluz Rojo Domingo; Roberta Vezza Alexander; Christopher C. Conlin; Son Do; Rana R. McKay; Vitali Moiseenko; Michael A. Liss; Jasmine Liu; Todd Pawlicki; Samuel Pena; Edmund M. Qiao; Brent S. Rose; Rhea Rupareliya; Ajay P. Sandhu; Jessica Scholey; Steven N. Seyedin; James J. Urbanic; Lee-Jen Wei; Tyler M. Seibert
errShare
errSave
Concurrent tissue and circulating tumor DNA analysis in renal cell carcinoma: insights from a multimodal database
err2026-05-01
err0
PREAI
errJani, Chinmay T.; Tran, Elizabeth; Jaeger, Ellen; Dong, Jianjie; Husni, Nabil; Stoppler, Melissa C.; Hockenberry, Adam J.; Mercer, Jacob; Pal, Sumanta; Agarwal, Neeraj; Choueiri, Toni K.; Rose, Brent; Bagrodia, Aditya; McKay, Rana R.
errShare
errSave
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapy
err2026-04-29
err0
errOAAI
errRana R. McKay; Nasreen Khan; Neal D. Shore; Guifang Chen; Vlasta Hlebec; Shankar Srinivasan; Daniel E. Spratt
errShare
errSave
Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errCesare Saitta; Giacomo Musso; Giuseppe Garofano; Hajime Tanaka; Dattatraya Patil; Margaret F. Meagher; Srinivas Vourganti; Edward Cherullo; Michael Liss; Marco Paciotti; Giovanni Lughezzani; Nicolò M. Buffi; Viraj Master; Yasuhisa Fujii; Rana R. McKay; Ithaar H. Derweesh
errShare
errSave
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
err2026-01-01
err0
PREAI
errLemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
Natural History and Risk Stratification of Biochemically Recurrent Prostate Cancer Following Definitive Radiation Therapy
err2026-01-01
err0
errOAAI
errRiviere, Paul; Morgan, Kylie M.; Nelson, Tyler; Minarim, Daniel Sabater; Deshler, Leah; Banegas, Matthew P.; Stewart, Tyler F.; Mckay, Rana R.; Javier-Desloges, Juan; Parsons, John Kellogg; Rose, Brent S.
errShare
errSave
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
err2025-12-17
err0
errOAAI
errSoumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey-Holden Prostate Cancer Academy Meeting
err2025-12-01
err0
errOAAI
errStoyanova, Tanya; Priceman, Saul J.; Ross, Ashley E.; Tran, Phuoc T.; Mckay, Rana R.; Pienta, Kenneth J.; Soule, Howard R.; Miyahira, Andrea K.
errShare
errSave
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer
err2025-11-11
err0
errOAAI
errRana R McKay, MD; Shayan S Nazari, PhD; Andrew Elliott, PhD; Jennifer R Ribeiro, PhD; Brent S Rose, MD; Pedro C Barata, MD, MSc; Deepak Kilari, MD; Rohan Garje, MD; Neeraj Agarwal, MD; Norm Smith, MD; Emmanuel S Antonarakis, MD; Aditya Bagrodia, MD; Himisha Beltran, MD
errShare
errSave
Retrospective Analysis of Racial Differences in Treatment Patterns and Prostate-Specific Antigen Responses Among Patients with Prostate Cancer Treated with Relugolix in the Veterans Health Administration
err2025-11-01
err0
errOAAI
errStephen J. Freedland; Krishnan Ramaswamy; Abhishek Kavati; Wei Gao; Juan F. Razo; Michele Cole; Benjamin Li; Hongbo Yang; Tracy Guo; Grace Chen; Rana R. McKay
errShare
errSave
Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617
err2025-11-01
err0
PREAI
errPanian, Justine; Henderson, Nicholas C.; Herchenhorn, Daniel; Barata, Pedro C.; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S.; Jindal, Tanya; Nauseef, Jones T.; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T.; Raychaudhuri, Ruben; Reichert, Zachery R.; Dorff, Tanya; Armstrong, Andrew J.; Wang, John; Alva, Ajjai; Mckay, Rana R.
errShare
errSave
Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population
err2025-11-01
err0
PREAI
errMcKay, Rana R.; Hong, Agnes; Razo, Juan F.; Flanders, Scott C.; Ferro, Christine; Shapoval, Mila; Li, Benjamin; Freedland, Stephen J.
errShare
errSave
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
err2025-10-27
err0
PREAI
errMatthew Smith; Josep Piulats; Tilman Todenhöfer; Jae-Lyun Lee; José Arranz Arija; Laura Mazilu; Arun Azad; Teresa Alonso-Gordoa; Ursula McGovern; Atish Choudhury; Lisa Horvath; Dingwei Ye; Weiqing Han; Hiroyoshi Suzuki; Hiroji Uemura; Rana McKay; Steven Ades; Aude Fléchon; Christopher Pieczonka; Maria S Fernandes; Maarten Hulstijn; Andrew Lithio; Karim Nacerddine; Neeraj Agarwal
errShare
errSave
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
err2025-10-14
err0
errOAAI
errKyle T. Helzer; Marina N. Sharifi; Jamie M. Sperger; Matthew R. Chrostek; Matthew L. Bootsma; Shannon R. Reese; Amy Taylor; Katie R. Kaufmann; Hannah Krause; Jennifer Schehr; Nan Sethakorn; David Kosoff; Christos E. Kyriakopoulos; Michael Bassetti; Grace Blitzer; John Floberg; Martin Sjöström; Andrew J. Armstrong; Himisha Beltran; Rana R. McKay; Felix Y. Feng; Ruth O’Regan; Kari B. Wisinski; Hamid Emamekhoo; Alex W. Wyatt; Joshua M. Lang; Shuang G. Zhao
errShare
errSave
Integrated efficacy and safety exposure response (ER) analysis of tivozanib (TIVO) for the treatment of renal cell cancer (RCC)
err2025-10-01
err0
errOAAI
errMcGregor, Bradley A.; Choueri, Toni; Albiges, Laurence; Beckermann, Katy; Barthelemy, Philippe; Iacovelli, Roberto; Emambux, Sheik; Molina-Cerrillo, Javier; Garmezy, Benjamin; Barata, Pedro C.; McKay, Rana; Chehrazi-Raffle, Alexander; Hammers, Hans J.; Heng, Daniel Yick Chin; Prins, Klaas; Jin, Bo; Cotreau, Monette; Braendle, Edgar E.; Lebedinsky, Claudia; Motzer, Robert
errShare
errSave
Lymphocyte heat shock signature predicts response to immune checkpoint blockade in renal cell carcinoma
err2025-10-01
err0
errOAAI
errBurns, Ethan; Kashima, Soki; Rout, Rishabh; Hugaboom, Miya; Ye, Zhaochen; Schindler, Nicholas; Dighe, Anasuya; Sun, Maxine; Lee, Gwo-Shu Mary; Xu, Wenxin (Vincent); Atkins, Michael B.; Signoretti, Sabina; McGregor, Bradley A.; McKay, Rana; Choueri, Toni; Braun, David
errShare
errSave